Article Details
Retrieved on: 2019-03-18 12:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>WINTON GROUP</b> Ltd grew its position in Nektar Therapeutics (NASDAQ:NKTR) by 40.3% during the 4th quarter, according to its most recent 13F filing ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here